Compounds > benzyloxycarbonylleucyl-leucyl-leucine-aldehyde

benzyloxycarbonylleucyl-leucyl-leucine-aldehyde and Long-QT-Syndrome

benzyloxycarbonylleucyl-leucyl-leucine-aldehyde has been researched along with Long-QT-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for benzyloxycarbonylleucyl-leucyl-leucine-aldehyde and Long-QT-Syndrome

Article	Year
Mechanisms of KCNQ1 channel dysfunction in long QT syndrome involving voltage sensor domain mutations. Science advances, 2018, Volume: 4, Issue:3 Mutations that induce loss of function (LOF) or dysfunction of the human KCNQ1 channel are responsible for susceptibility to a life-threatening heart rhythm disorder, the congenital long QT syndrome (LQTS). Hundreds of Topics: Cell Membrane; HEK293 Cells; Humans; KCNQ1 Potassium Channel; Leupeptins; Long QT Syndrome; Loss of Function Mutation; Magnetic Resonance Spectroscopy; Mutant Proteins; Mutation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Domains; Protein Folding; Protein Structure, Secondary; Proteolysis	2018

Article

Year

Mechanisms of KCNQ1 channel dysfunction in long QT syndrome involving voltage sensor domain mutations.

Science advances, 2018, Volume: 4, Issue:3

Mutations that induce loss of function (LOF) or dysfunction of the human KCNQ1 channel are responsible for susceptibility to a life-threatening heart rhythm disorder, the congenital long QT syndrome (LQTS). Hundreds of

Topics: Cell Membrane; HEK293 Cells; Humans; KCNQ1 Potassium Channel; Leupeptins; Long QT Syndrome; Loss of Function Mutation; Magnetic Resonance Spectroscopy; Mutant Proteins; Mutation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Domains; Protein Folding; Protein Structure, Secondary; Proteolysis

2018